ATE127778T1 - Zwischenprodukte für difluoroglutamsäurekonjugate mit folaten und antifolaten zur behandlung von neoplastischen krankheiten. - Google Patents

Zwischenprodukte für difluoroglutamsäurekonjugate mit folaten und antifolaten zur behandlung von neoplastischen krankheiten.

Info

Publication number
ATE127778T1
ATE127778T1 AT91105767T AT91105767T ATE127778T1 AT E127778 T1 ATE127778 T1 AT E127778T1 AT 91105767 T AT91105767 T AT 91105767T AT 91105767 T AT91105767 T AT 91105767T AT E127778 T1 ATE127778 T1 AT E127778T1
Authority
AT
Austria
Prior art keywords
folates
antifolates
treatment
neoplastic diseases
intermediate products
Prior art date
Application number
AT91105767T
Other languages
English (en)
Inventor
Philippe Bey
Michael H Kolb
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Application granted granted Critical
Publication of ATE127778T1 publication Critical patent/ATE127778T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/24—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one carboxyl group bound to the carbon skeleton, e.g. aspartic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/06—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4
    • C07D475/08—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/36—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Cephalosporin Compounds (AREA)
AT91105767T 1990-04-12 1991-04-11 Zwischenprodukte für difluoroglutamsäurekonjugate mit folaten und antifolaten zur behandlung von neoplastischen krankheiten. ATE127778T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/508,874 US5066828A (en) 1990-04-12 1990-04-12 Difluoroglutamic acid conjugates with folates and anti-folates for the treatment of neoplastic diseases

Publications (1)

Publication Number Publication Date
ATE127778T1 true ATE127778T1 (de) 1995-09-15

Family

ID=24024432

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91105767T ATE127778T1 (de) 1990-04-12 1991-04-11 Zwischenprodukte für difluoroglutamsäurekonjugate mit folaten und antifolaten zur behandlung von neoplastischen krankheiten.

Country Status (18)

Country Link
US (1) US5066828A (de)
EP (1) EP0451835B1 (de)
JP (1) JP2970698B2 (de)
KR (1) KR910018344A (de)
CN (1) CN1055740A (de)
AT (1) ATE127778T1 (de)
AU (1) AU635628B2 (de)
CA (1) CA2040059A1 (de)
DE (1) DE69112885T2 (de)
ES (1) ES2079507T3 (de)
FI (1) FI911778L (de)
HU (1) HU911195D0 (de)
IE (1) IE911230A1 (de)
IL (1) IL97819A0 (de)
NO (1) NO911418L (de)
NZ (1) NZ237735A (de)
PT (1) PT97338A (de)
ZA (1) ZA912590B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5286726A (en) * 1990-04-12 1994-02-15 The Regents Of The University Of Michigan Difluoroglutamic acid conjugates with folates and anti-folates for the treatment of neoplastic diseases
AU4220193A (en) * 1992-04-29 1993-11-29 Sri International Deazaaminopterins for treatment of inflammation
US6323205B1 (en) * 1996-07-17 2001-11-27 Sloan-Kettering Institute For Cancer Research Combinations of 10-propargyl-10-deazaaminopterin and taxols and methods of using same in the treatment of tumors
DE19904812A1 (de) 1999-02-05 2000-08-10 Basf Ag Verfahren zur Herstellung von Folsäure
CN101646639A (zh) 2007-04-11 2010-02-10 默克阿泼洛发股份公司 18f-标记的叶酸
WO2008125615A1 (en) * 2007-04-11 2008-10-23 Merck Eprova Ag 18 f-labelled folates
US9901578B2 (en) 2007-08-17 2018-02-27 Allos Therapeutics, Inc. Combination of 10-propargyl-10-deazaaminopterin and erlotinib for the treatment of non-small cell lung cancer
US20090048262A1 (en) * 2007-08-17 2009-02-19 Allos Therapeutics, Inc. Combination of 10-propargyl-10-deazaaminopterin and erlotinib for the treatment of non-small cell lung cancer
US20100248249A1 (en) * 2007-08-17 2010-09-30 Allos Therapeutics, Inc. Methods for Assessing Cancer for Increased Sensitivity to 10-Propargyl-10-Deazaaminopterin by Assessing Egfr Levels
CA2736861C (en) 2008-10-10 2017-11-14 Roger Schibli 18f-labelled folates as pet radiotracers
WO2011096947A1 (en) * 2010-02-02 2011-08-11 Allos Therapeutics, Inc. Optically pure diastereomers of 10-propargyl-10-deazaaminopterin and methods of using same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH630380A5 (de) * 1977-08-12 1982-06-15 Lonza Ag Verfahren zur herstellung von l-methotrexat.
US4136101A (en) * 1978-02-03 1979-01-23 American Cyanamid Company Process for preparing dialkyl (p-aminobenzoyl) glutamates
US4247453A (en) * 1978-09-13 1981-01-27 Abbott Laboratories Folic acid derivatives for use in radioimmunoassay
IT1215169B (it) * 1985-12-17 1990-01-31 Rotta Research Lab Derivati alchil ossigenati degli acidi glutammico ed aspartico ad attivita antagonista su polipeptidi bioattivi e procedimento per la loro preparazione
NZ219971A (en) * 1986-06-06 1989-08-29 Univ Princeton Tetrahydropyrido (2,3-d pyrimidine derivatives and pharmaceutical compositions
EP0341837A3 (de) * 1988-04-15 1990-08-16 The Wellcome Foundation Limited Glutamsäurederivate

Also Published As

Publication number Publication date
JPH04235144A (ja) 1992-08-24
JP2970698B2 (ja) 1999-11-02
PT97338A (pt) 1992-01-31
IE911230A1 (en) 1991-10-23
NZ237735A (en) 1993-08-26
FI911778A7 (fi) 1991-10-13
HU911195D0 (en) 1991-10-28
NO911418D0 (no) 1991-04-11
CN1055740A (zh) 1991-10-30
US5066828A (en) 1991-11-19
DE69112885D1 (de) 1995-10-19
IL97819A0 (en) 1992-06-21
FI911778A0 (fi) 1991-04-12
DE69112885T2 (de) 1996-02-15
CA2040059A1 (en) 1991-10-13
ZA912590B (en) 1992-01-29
EP0451835A1 (de) 1991-10-16
ES2079507T3 (es) 1996-01-16
KR910018344A (ko) 1991-11-30
EP0451835B1 (de) 1995-09-13
AU635628B2 (en) 1993-03-25
AU7416591A (en) 1991-10-17
FI911778L (fi) 1991-10-13
NO911418L (no) 1991-10-14

Similar Documents

Publication Publication Date Title
PL342078A1 (en) Inhibition of raf kinase using symmetrical and dissymmetrical substituted dimethylureas
PT1042305E (pt) Inibicao de quinase p38 utilizando difenilureias simetricas e assimetricas
EE200000318A (et) Uudsed ühendid
EP0335901A4 (en) Methods and compositions for the treatment of non-ige-mediated diseases
DE69736441D1 (de) Pharmazeutische zusammensetzung zur behandlung von neurologischen und neuropsychiatrischen erkrankungen
DE69830336D1 (de) Ein kovalentes konjugat von clozapine und einer fettsäure und dessen verwendung zur behandlung von schizophrenie
ATE132149T1 (de) Konjugate von difluoroglutaminsäure mit fölaten und antifölaten für die behandlung von neoplastischen krankheiten
ATE209492T1 (de) Verwendung von 1,2,4-triazolo(1,5-c)pyrimidine heterocyclischen analogen zur herstellung von arzneimitteln zur behandlung von zerebrovascularen störungen
DE69112885D1 (de) Zwischenprodukte für Difluoroglutamsäurekonjugate mit Folaten und Antifolaten zur Behandlung von neoplastischen Krankheiten.
ATE91628T1 (de) Sauerwiderstehender fibroblast-wachstumsfaktor, zubereitung zur behandlung von magen-darmweggeschw¨rkrankheiten.
BG100930A (bg) Фармацевтични състави и лекарствени средства за профилактика и лечение на ендотелиални нарушения
DE69523654D1 (de) Verwendung von Ascorbyl-gamma-Linolenat und von Ascorbyl-dihomo-gamma-linolenat zur Behandlung von Asthma, Krebs, kardiovaskulären und inflammatorischen Erkrankungen
ATE271861T1 (de) Verwendung von nmda-antagonisten und/oder natriumkanalantagonisten zur behandlung von entzündlichen erkrankungen
DE69010294D1 (de) Verwendung von Antiprogestomimetika zur Stimulierung des Eisprungs.
DE3885022D1 (de) Thiosulfinsäurederivate, und die Verwendung von Thiosulfinsäurederivaten zur Herstellung von Arzneimitteln für die Behandlung von Entzündungserkrankungen.
IT1223395B (it) Composti ad attivita' cardiovascolare
MY103593A (en) Bicyclic compounds, their use as pharmaceuticals, their preparation, and intermediates useful in their preparation
TR199701605A2 (xx) S�lfonamid-substit�e edilmi� bile�ikler
ES8801624A1 (es) Procedimiento para preparar disulfuros heterociclicos
DE69113773D1 (de) Verwendung von 3-aryl-5-alkylthio-4H-1,2,4-triazolen zur Behandlung von Überreflexen infolge von Rückenmarkstrauma.
DE59410340D1 (de) Verwendung von Bradykinin-Antagonisten zur Behandlung von Viruserkrankungen
ATE121935T1 (de) D-asparaginsäure-beta-hydroxamat zur behandlung viraler infektionen und tumoren.

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee